| Name | Title | Contact Details |
|---|
Forever North Partners (FNP) is a purpose-driven company partnering with high-achieving businesses poised for the next phase of growth. Focused on companies possessing unique, disruptive technologies or services, FNP is dedicated to facilitating your ascent to new heights. FNP services offerings: Investees and Investors: FNP excels in collaborating with dynamic, forward-thinking companies seeking additional investment capital to fuel their growth ambitions. Leveraging its extensive network, FNP identifies investors whose interests align with your companies potential. Operational Excellence Services: Boasting over a century of collective industry experience, FNP applies its proven Market-Driven Application Approach to craft precise positioning and messaging strategies empowering your company to penetrate competitive markets, secure new customers, and drive sales. FNP crafts targeted sales and marketing campaigns complete with compelling collateral, ensuring effective outreach to high-value customers within specific application spaces. FNPs network of key opinion leaders (KOLs) will amplify your corporate messaging to drive top-line growth. Executive Recruiting: FNP understands that success hinges on having the right people in pivotal roles. While adopting the necessary tools for growth is crucial, it is the people who epitomize your values and culture that truly propel your company forward. Leadership, especially, demands exceptional individuals who embody your vision and are committed to realizing your companys mission. FNP has earned a stellar reputation for identifying and securing high-caliber, high-performance executives capable of translating your vision into reality. Regulatory Affairs: Navigating the intricate landscape of the life sciences market demands a profound understanding of ever-changing regulatory compliance issues. Reach regulatory excellence with FNP - Your Trusted Life Sciences Partner. Let FNP guide you on your journey to success.
Liverpool Football Club was founded in 1892 and is one of the worlds most historic and famous football clubs. Honours include 19 League Titles, eight FA Cups, ten League Cups, six European Cups, three UEFA Cups, four European Super Cups, 16 Charity Shields, one FIFA Club World Cup, two Womens Super League and one Womens Championship. As a socially responsible club, Liverpool FC is proud of its heritage and plays a proactive role in its communities through its official charity, Liverpool FC Foundation, which helps children and families in Merseyside and beyond, and the Red Neighbours programme, which creates events and experiences specifically aimed at improving the lives of those living in and around the Anfield area (L4, L5 and L6). Liverpool FC is a global brand and works with leading edge commercial partners around the world providing unparalleled commercial opportunities.
American Global is a prominent privately held insurance and surety brokerage firm based in Miami, Florida. With over 100 locations worldwide, the company specializes in construction risk management. Their mission focuses on understanding client needs and creating tailored solutions, fostering long-term partnerships to enhance the brokerage experience. The firm offers a wide range of services, including managing complex surety programs, providing consultative insurance solutions, and designing captive finance options. They also create Controlled Insurance Programs (CIPs) and Subcontractor Default Insurance (SDI) programs to help clients minimize costs and manage risks effectively. American Global serves a diverse clientele in the construction industry, including general contractors and construction management firms. The company promotes a culture of innovation and collaboration, encouraging employees to contribute to the future of construction brokerage. American Global has been recognized as one of the "Best Places to Work" by Business Insurance for two consecutive years, reflecting their commitment to employee satisfaction and development.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.